CBIO
Crescent Biopharma
CBIO
CBIO
85 hedge funds and large institutions have $668M invested in Crescent Biopharma in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 1.09% → 1.08% (-0.01%)
9% less capital invested
Capital invested by funds: $730M → $668M (-$62.6M)
Holders
85
Holding in Top 10
1
Calls
$1.53M
Puts
$1.23M
Top Buyers
| 1 | +$21M | |
| 2 | +$5.6M | |
| 3 | +$5.12M | |
| 4 |
JG
Jefferies Group
New York
|
+$2.46M |
| 5 |
Axa
Paris,
France
|
+$1.63M |
Top Sellers
| 1 | -$8.68M | |
| 2 | -$4.7M | |
| 3 | -$4.03M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.43M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.26M |